Form 4: Molina Healthcare Director Steven Orlando Acquires Shares Under Equity Incentive Plan
SEC Form 4 Filing
Director Steven J. Orlando acquired 136 shares of Molina Healthcare common stock on April 1, 2024, as part of the company's 2019 Equity Incentive Plan.
Summary
- On April 1, 2024, Steven J. Orlando, a director of Molina Healthcare, Inc., acquired 136 shares of common stock.
- The acquisition was part of the Issuer's 2019 Equity Incentive Plan, related to his services as a Director.
- The shares were granted at a price of $404.20, representing the closing price of Molina Healthcare's common stock on that day.
- The grant is part of an annual equity award to each director, valued at $220,000, with quarterly grants of $55,000.
- Following the transaction, Orlando directly owns 1,500 shares through his 401(k) plan and indirectly owns 18,837 shares held by the Orlando Family Trust.
- Jeff D. Barlow, acting as power of attorney for Steven J. Orlando, signed the report on April 2, 2024.
- A Limited Power of Attorney document appoints Jeff D. Barlow and Codruta Catanescu to execute and file SEC forms on behalf of Steven Orlando.
Sentiment
Score: 7
Explanation: The document reflects a routine insider transaction, which is generally neutral to positive as it indicates director's continued investment in the company. The sentiment is slightly positive due to the alignment of interests between the director and shareholders.
Positives
- Director's acquisition of shares demonstrates confidence in the company.
- The equity incentive plan aligns director's interests with those of shareholders.
Future Outlook
NA
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It reflects standard compensation practices for board members.
Comparison to Industry Standards
- Equity compensation for board members is a common practice among publicly traded healthcare companies.
- Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize equity-based compensation to align the interests of their directors with those of shareholders.
- The size and structure of the equity awards are generally benchmarked against peer companies to ensure competitiveness and attract qualified board members.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2011-02-16 | Date of the Limited Power of Attorney execution. |
| 2024-04-01 | Date of the stock transaction. |
| 2024-04-02 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.